期刊文献+

盐酸芬戈莫德对大鼠颈动脉球囊损伤后1型和3型1-磷酸鞘氨醇受体表达的影响

Effects of fingolimode on expression of sphingosine1-phosphate receptor 1and 3in rats carotid artery after balloon injury
下载PDF
导出
摘要 目的探讨新型免疫抑制剂盐酸芬戈莫德对大鼠颈动脉球囊损伤后1型和3型1-磷酸鞘氨醇受体(S1P1,S1P3)表达的影响。方法 60只SD大鼠随机分为假手术组(n=15)、阴性对照组(n=15)、模型组(n=15)和药物处理组(n=15),采用球囊损伤的方法制备大鼠颈动脉球囊损伤模型,于术后3天、7天和21天取材,行HE染色观察其组织学变化,采用Real-time PCR(RT-PCR)检测大鼠血管中丝氨酸/苏氨酸蛋白激酶2(AKT2)的表达,Western Blot检测大鼠血管中S1P1和S1P3的表达水平。结果 HE染色显示模型组与其他组相比血管增殖明显;RT-PCR显示AKT2在药物处理组的表达低于模型组,但只在7天时差异有统计学意义(P<0.05),在同一时间点模型组和药物处理组的表达量均高于假手术组和阴性对照组(P均<0.05),假手术组和阴性对照组在各时间点的表达量差异均无统计学意义(P均>0.05);Western Blot在球囊损伤初期S1P1和S1P3表达增加,随着时间推移特别是药物干预作用后,到21天时的表达与正常组织相比无明显差异。结论S1P1和S1P3参与了球囊损伤后平滑肌细胞的迁移与增殖,新型免疫抑制剂盐酸芬戈莫德可以抑制AKT2及S1P1和S1P3的表达,减轻球囊损伤后的再狭窄。 Objective To assess effect of fingolimode on the expression of sphingosinel-phosphate receptor 1/sphingo- sinel-phosphate receptor 3 (S1P1/S1P3) in rat carotid artery after balloon injury. Methods Sixty SD rats were equally and randomly divided into the sham operation group, the negative control group, the balloon injury group and the drug inter- vention group. Rats" carotid artery injury models were established with balloon injury. Carotid arteries of rat were extracted at 3 d, 7 d and 21 d after operation. The vessels were after operation stained by hematoxylin-eosin to observe the proliferation. Real-time PCR (RT-PCR) was used to assay the expression of serine/threonine kinases 2 (AKT2). The expression of S1P1 and S1P3 in target vessels was assessed by Western blot. Results Compared with other groups, the proliferation of the balloon injury group was significant. The expression of AKT2 mRNA level in drug intervention group was lower than that in the balloon injury group, but there was statistical difference between those two groups at 7 d (P〈0.05). The ex- pression level in the drug intervention group and balloon injury group were higher than that in the sham operation group and the negative control group (all P〈0.05). There was no statistical difference between sham operation group and the negative control group (P〉0.05). Western blot showed that at the initial of the balloon injury the expression of S1P1 and S1P3 was in the high level. Compared with 7 d, the expression of S1P1 and S1P3 was in the lower level in 21 d, especially after treated with fingolimode. Conclusion S1P1 and S1P3 plays an important role in migration and proliferation of vascular smooth muscle cells. Fingolimode can attenuate the restenosis by inhibiting the expression of AKT2, S1P1 and S1P3.
出处 《中国介入影像与治疗学》 CSCD 2014年第11期739-743,共5页 Chinese Journal of Interventional Imaging and Therapy
基金 甘肃省自然科学基金(1010RJZA101)
关键词 盐酸芬戈莫德 球囊损伤 再狭窄 1型1-磷酸鞘氨醇受体 3型1-磷酸鞘氨醇受体 Fingolimode Balloon injury Restenosis Sphingosinel-phosphate receptor 1 Sphingosinel-phosphate receptor 3
  • 相关文献

参考文献14

  • 1Kang SJ, Mintz GS, Park DW, et al. Mechanisms of in-stent restenosis after drug-eluting stent implantation: Intravascular ul- trasound analysis. Circ Cardiovasc Interv, 2011,4 (1):9-14.
  • 2Guildford AL, Stewart H J, Morris C, et al. Substrate-induced phenotypic switches of human smooth muscle cells: An in vitro study of in-stent restenosis activation pathways. J R Soc Inter- face, 2011,8(58) : 641-649.
  • 3Rajkumar VS, Shiwen X, Bostrom M, et al. Platelet-derived growth factor-beta receptor activation is essential for fihrohlast and pericyte recruitment during cutaneous wound healing. Am J Pathol, 2006,169(6) :2254-65.
  • 4Wamhoff BR, Lynch KR, Macdonald TL, et al. Sphingosine-1- phosphate receptor subtypes differentially regulate smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol, 2008, 28 (8) : 1454-1461.
  • 5Tsao AS, McDonnell T, Lam S, et al. Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: Implications for lung cancer prevention studies. Cancer Epidemiol Biomarkers Prey, 2003,12(7) :660-664.
  • 6Francy JM, Nag A, Conroy EJ, et al. Sphingosine kinase 1 ex- pression is regulated by signaling through PI3K, AKT2, and mTOR in human coronary artery smooth muscle cells. Biochim Biophys Acta, 2007, 1769(4) :253-265.
  • 7Marfe G, Di Stefano C, Gambacurta A, et al. Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells. Exp Hematol, 2011,39(6) :653-665, e6.
  • 8Takuwa Y, Okamoto Y, Yoshioka K, et al. Sphingosine-l-phos- phate signaling and biological activities in the cardiovascular sys- tem. Biochim Biophys Acta, 2008,1781(9):483-488.
  • 9Birker-Robaczewska M, Studer R, Haenig I3, et al. bFGF in- duces S1P1 receptor expression and functionality in human pulmo- nary artery smooth muscle cells. J Cell Biochem, 2008, 105 (4) : 1139-1145.
  • 10Waeber C, Blondeau N, Salomone S. Vascular sphingosine-1- phosphate S1P1 and S1P3 receptors. Drug News Perspect, 2004,17(6) : 365-382.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部